GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India flag India · Delayed Price · Currency is INR
2,601.00
+7.95 (0.31%)
At close: Aug 10, 2026

BOM:500660 Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, BOM:500660 stock has a consensus rating of "Buy" and an average price target of ₹3,081. The average 1-year stock price forecast is 18.45% higher than the current stock price, while the lowest is ₹2,870 (+10.34%) and the highest is ₹3,500 (+34.56%).

Price Target: ₹3,081 (+18.45%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₹2,870₹3,081₹2,977₹3,500
Change+10.34%+18.45%+14.46%+34.56%

Analyst Ratings

The average analyst rating for BOM:500660 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy222222
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total444444

Financial Forecast

Revenue This Year
42.53B
from 38.22B
Increased by 11.28%
Revenue Next Year
47.17B
from 42.53B
Increased by 10.91%
EPS This Year
68.53
from 60.11
Increased by 14.00%
EPS Next Year
78.88
from 68.53
Increased by 15.10%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
32.78B32.52B34.54B37.49B38.22B42.53B
Revenue Growth
12.05%-0.80%6.21%8.56%1.93%11.28%
Gross Profit
19.00B19.48B20.99B23.35B24.46B27.30B
Gross Margin
57.96%59.89%60.76%62.29%64.00%64.20%
Operating Income
6.99B7.48B8.39B11.14B12.48B14.62B
Net Income
16.95B6.11B5.90B9.28B10.36B11.61B
EPS
----60.1168.53
EPS Growth
----10.25%14.00%
Forward PE
42.3035.5844.1649.8834.1637.96
Dividend / Share
30.0032.0032.0042.0057.0029.50
Dividend Growth
-6.67%-31.25%35.71%-48.25%
Free Cash Flow
10.10B1.56B6.70B11.62B7.29B12.00B
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue20272028
High43.7B
Avg42.5B
Low42.1B

Revenue Growth

Revenue Growth20272028
High
14.3%
Avg
11.3%
Low
10.1%

EPS Forecast

EPS20272028
High69.80
Avg68.53
Low67.10

EPS Growth

EPS Growth20272028
High
16.1%
Avg
14.0%
Low
11.6%